Skip to main content

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

Biopharma Sales Resilience through Economic Recession

Click here to download the full presentation.

Summary

• Biopharma generally outperforms other sectors, even other healthcare sectors, in a recession.
• But, some drug classes fare better than others. Resilient branded drug classes tend to be highly effective, treat severe and/or acute diseases, and face little competitive pressure.
• For those drug classes that address less severe diseases or face low-cost alternatives, drug makers need to work to ensure continued access and adherence.


###